Clinical Trial Update: TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer [Phase 2]

View source ↗

Summary

TAPUR is a Phase 2 study testing FDA-approved cancer drugs that target specific tumor gene abnormalities in patients with advanced cancers; the trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-hodgkin Lymphoma

Snippet

Sponsor: American Society of Clinical Oncology | Conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma | Phase 2 | Status: RECRUITING